Clinical Trials Directory

Trials / Completed

CompletedNCT03448640

Efficacy of Mydriatic Drops in Premature Infants

Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Bulent Ecevit University · Academic / Other
Sex
All
Age
32 Weeks – 34 Weeks
Healthy volunteers
Not accepted

Summary

Because of the neonatologists reported that some infants had suffered from vomiting, bradycardia, hypotonia, and aspiration risk about 30-60 minutes after the fundus examination in the intensive care unit. The investigators observed the pupil dilation effects and side effects of tipple instillation of phenylephrine 2.5% plus tropicamide 0.5% ophthalmic drop combination which the investigators routinely used in ROP examination.

Detailed description

Purpose: To determine effect and vital change after topical application of phenylephrine 2.5% and tropicamide 0.5% three times for retinopathy of prematurity (ROP) examination in preterm infants. Methods: Pupillary diameter, blood pressure, pulse rate, and oxygen saturation were monitored before, and after up to 24 hours 60 ROP screening examinations.

Conditions

Interventions

TypeNameDescription
DRUGDrug used in the examination of premature infants.to investigate side effects of eye drops used

Timeline

Start date
2016-01-15
Primary completion
2017-10-15
Completion
2017-12-15
First posted
2018-02-28
Last updated
2018-02-28

Source: ClinicalTrials.gov record NCT03448640. Inclusion in this directory is not an endorsement.